SBIR-STTR Award

Device To Quality Sperm Count And Other Semen Parameters
Award last edited on: 2/25/02

Sponsored Program
SBIR
Awarding Agency
NIH : NICHD
Total Award Amount
$99,993
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Diarmaid H Douglas-Hamilton

Company Information

Hamilton Thorne Research Inc (AKA: Hamilton-Thorne Bio Sciences)

100 Cummings Center Suite 465E
Beverly, MA 01915
   (978) 921-2050
   info@hamiltonthorne.com
   www.hamiltonthorne.com
Location: Single
Congr. District: 06
County: Essex

Phase I

Contract Number: 1R43HD036146-01A1
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
1998
Phase I Amount
$99,993
We propose to build a device to quantify new simplified semen assays. Novel colorimetric assays for semen evaluation have recently been validated in independent clinical studies and will be introduced commercially in 1997. These MARQ (male reproductive quality) assays operate by filtering, staining and visually examining sperm cells. These assays comprise rapid, inexpensive diagnostic kits for a physician's office, to screen those patients who should be referred to a fertility specialist. They provide simple, semi-quantitative analysis of selected semen parameters including sperm concentration, sperm viability, and leukocyte count. Semen analysis by microscope is CLIA-classified as highly complex, and is subject to significant observer error. Therefore an improved measure of sperm concentration and other parameters is needed if patient screening is to be permissible in the physician's office. We propose to develop a prototype semen-evaluation colorimeter for application both to low- and to high-volume settings. The Prototype is designed to quantitate the color endpointproduced by the MARQ assays. It combines recently-developed optical sources, microcomputer control, CPU-controlled strobed light sources and detectors together with rapid analog/digital conversion to give an accurate, compact, simple and inexpensive instrument. The Prototype reader will be designed, built, tested and validate.Proposed Commercial Application:The Prototype and assays will be used by general practitioners, OBGYNs, urologists, and fertility clinics. More than 11 million semen analyses are performed annually world wide for infertility screening, quality control in sperm banks, male contraceptive research and post-vasectomy follow-up. The low price and the anticipated accuracy indicates a potential market of more than 100,000 sites. The accuracy, low cost and ease-of-use of the proposed MARQ Reader should prove particularly important in the managed care medical environment as well as in less developed countries.

Thesaurus Terms:
biomedical equipment development, colorimetry, diagnosis design /evaluation, semen, sperm analysis biomedical automation, computer assisted diagnosis, cytodiagnosis, cytotoxicity, diagnosis quality /standard, fertility, leukocyte count, rapid diagnosis human subject, statistics /biometry

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----